Trestle Biotherapeutics Licenses Innovations from Harvard University to Develop 3D Biofabricated Tissues to Treat Kidney Failure - read this article along with other careers information, tips and advice on BioSpace
Many future gene and cell therapies to treat diseases like cancer, rare genetic and other conditions could be enhanced in their efficacy, persistence, and predictability by so-called "genomic safe harbors (GSHs)."
When University of Vermont researcher Josh Bongard and his colleagues in Massachusetts began working on a project to build robots using artificial intelligence and frog.